The U.S. Food and Drug Administration released more than 200 of its so-called complete response letters from its archive on Thursday, in a push to increase transparency under Health Secretary Robert F.

The trove of more than 200 letters is part of a pledge of transparency from the agency, with the intention to increase public insight into the reasons new drug and biologics applications got rejected.

The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | The FDA has released an "initial batch" of more than 200 complete response letters (CRLs) in efforts to boost transparency.